check_url/it/65793?article_type=b

Quantifying Vaccine-Induced Neutralizing Antibodies in SARS-CoV-2 Variants

September 08, 2023
, ,

Summary

This protocol describes the application of a novel hybrid alphavirus-SARS-CoV-2 pseudovirus (Ha-CoV-2) as a platform for rapid quantification of infectivity of SARS-CoV-2 variants and their sensitivity to neutralizing antibodies.